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Polyamines are essential for Trypanosoma cruzi, the causative agent of Chagas disease. As T. cruzi b e h a v e sa san a t u r a la u x o t r o p h i c
organism, it relies on host polyamines biosynthesis. In this paper we obtained a double-transfected T. cruzi parasite that expresses
the green ﬂuorescent protein (GFP) and a heterologous ornithine decarboxylase (ODC), used itself as a novel selectable marker.
These autotrophic and ﬂuorescent parasites were characterized; the ODC presented an apparent Km for ornithine of 0.51 ±
0.16mM and an estimated Vmax value of 476.2nmoles/h/mg of protein. These expressing ODC parasites showed higher
metacyclogenesis capacity than theauxotrophic counterpart, supporting the idea thatpolyamines are engaged in this process.This
double-transfected T. cruzi parasite results in a powerful tool—easy to follow by its ﬂuorescence—to study the role of polyamines
in Chagas disease pathology and in related processes such as parasite survival, invasion,proliferation,metacyclogenesis,and tissue
spreading.
1.Introduction
Protozoan parasites cause disease, death, and severe social
and economic losses, particularly in developing countries.
Trypanosoma cruzi is the causative agent of Chagas disease,
which aﬀects 16–18 million people mainly in Latin America
[1, 2].
T. cruzi is a digenetic parasite whose life cycle involves an
insect vector (from Reduviidae family) and a vertebrate host.
The parasite undergoes deep morphological, biochemical,
and physiological changes as an adaptive response to the ex-
treme environmental variations that it faces around the life
cycle.The epimastigoteform(E)isa proliferativeandnonin-
fective extracellular stage, present in the insect gut. At the
insect rectum, it diﬀerentiates to metacyclic trypomastigote
(MT), an infective stage present in the contaminated insect
faeces, which enter the vertebrate host through the insect
wound or via mucosal membranes. Once inside, the trypo-
mastigotes invade diﬀerent kinds of cells, including macro-
phages, ﬁbroblasts, and muscle cells [3]. There, they trans-
form to amastigote stage and replicate to reach a critical nu-
mber of parasites per cell, then they diﬀerentiate to blood
stream trypomastigotes (BT), host cells burst, and release
trypomastigotes, which either infect other cells or get sucked
up by a bug vector [4–6]. The recent construction of stable
green ﬂuorescent protein (GFP) expressing T. cruzi strains
has resulted in a useful tool to follow processes as cell inva-
sion and infection progression [7, 8].
Polyamines are ubiquitous cell compounds essential for
macromolecular biosynthesis [9, 10] and normal cell sur-
vival, proliferation and diﬀerentiation [11–13]. Several stud-
ies related to polyamine metabolism in pathogenic protozoa2 Enzyme Research
havebeen carried out with the aim to aﬀect theproliferation,
infectivity, or diﬀerentiation of these organisms and ﬁnd
new therapeutic targets against parasitic diseases [1, 14, 15].
With this kind of approach it was discovered that the acute
infections of Trypanosoma brucei brucei in mice as well as the
human African sleeping sickness, caused by T. brucei gambi-
ense,c a nb et r e a t e db yα-diﬂuoromethylornithine (DFMO),
the speciﬁc and irreversible ornithine decarboxylase (ODC)
inhibitor [16–18].
The naturally occurring polyamines in most cell types,
including mammalian cells, are putrescine (actually a diam-
ine precursor), spermidine and spermine, while in trypano-
somes this last polyamine was only found in trace amounts
[11, 19, 20]. There are some diﬀerences related to polyamine
biosynthetic enzymes between mammalian cells and par-
asites; however, polyamines are essential for both kinds of
organisms. In fact, only two kinds of wild-type cells, Halo-
bacteriales and Methanobacteriales, have been described
with the ability to grow in the absence of a detectable pol-
yamine concentration [21, 22].
The main route of putrescine biosynthesis is through the
ornithinedecarboxylationusingtheenzymeornithinedecar-
boxylase (ODC; EC 4.1.1.17), key enzyme capable of regu-
lating cell growth and diﬀerentiation [22–24]. Many plants,
bacteria and some speciﬁc mammalian tissues possess an
alternative pathway by arginine decarboxylase (ADC; EC
4.1.1.19) where arginine is converted to putrescine via the
intermediate agmatine [25–29].
The next step in polyamine biosynthesis is catalyzed by
spermidine synthase (SpdS; EC 2.5.1.16) that transfers an
aminopropyl group from the donor decarboxylated S-ade-
nosylmethionine (dcAdoMet)to putrescine, producingsper-
midine. Spermine synthase (SpmS; EC 2.5.1.22) transfers a
second aminopropyl group from dcAdoMet producing sper-
mine. This enzyme is generally absent in the protozoan par-
asites; however, T. cruzi w o u l db ea ne x c e p t i o ns i n c ei t s
genome presents two aminopropyltransferase genes, one of
them a putative SpmS. This function has been proposed in
silico but not functionally validated yet [1, 30].
Thebiosynthesisofpolyamines isirreversible,butthereis
a route for polyamine back-conversion involving two steps: a
spermidine/spermine N-acetyltransferase (EC 2.3.1.57) and
polyamine oxidase (PAO; EC 1.5.3.13) [31, 32].
In trypanosomatids, spermidine plays a central role be-
causeitistheprecursorofthederivativeN1,N8-bis-glutathi-
onyl-spermidine (trypanothione). This compound, unique
in these protozoan organisms, is essential to maintain the
redoxequilibriumin the parasite cell and playsthemetabolic
and antioxidant functions of glutathione [33–35]. For this
and other reasons, it is not surprising that polyamines are
essential for survival and proliferation of T. cruzi [36–40].
However, T. cruzi is one of the extremely few eukaryotic
organisms auxotrophic for polyamines. We have previously
demonstrated that T. cruzi epimastigotes are unable to
synthesize putrescine de novo because they contain neither
O D Cn o rA D Ce n z y m a t i ca c t i v i t y ,d u et ot h ea b s e n c eo f
O D Ca n dA D Cg e n e s[ 38, 41, 42]. This conclusion is also
supported by data from the T. cruzi genome project [30].
Polyamines seem to be crucial for the other T. cruzi stages,
particularly in trypomastigote internalization process in, at
least, some cellular types, and infection progression as well
as for other related parasites infection [6, 43–46]. Since
parasites live inside other organisms, numerous essential
metabolites can be obtained directly from the host without
the need to synthesize them [47]. It seems to be the case
for polyamines, where its uptake systems from the parasite
together with the ODC enzymatic activity from the host are
a concerted and critical system for T. cruzi survival and host
infection.
In this work we obtained a double-transfected T. cruzi
strain that expresses the green ﬂuorescent protein (GFP) and
a heterologous ODC enzyme. The latter is encoded by the
ODCgene,anauxotrophyrescuinggeneusedhereasaselect-
ablemarker. Thenwe selecteda Y-GFP-ODC clonewith high
expression of both GFP [7]a n dO D Ca c t i v i t y[ 38]. These
autotrophic and ﬂuorescent parasites were characterized as
well asthe heterologousODCenzyme activity. AsT. cruzi is a
naturally auxotrophic organism for polyamines, the autotro-
phy acquisition could provide information about the role of
polyamines in processes such as parasite survival, invasion,
proliferation, metacyclogenesis and tissue spreading, under
diﬀerent conditions of polyamines availability natural or
induced with polyamine inhibitors; the green ﬂuorescent
protein allows to easily follow those processes microscopi-
cally. Therefore, the double-transfected T. cruzi parasite is a
powerful new tool to study the role of polyamines, naturally
provided by the host ODC, in the parasite cell cycle. This
would help to better understand Chagas disease pathology
and to ﬁnd targets for new therapies.
2.Materialsand Methods
2.1. Chemicals. Brain heart infusion, tryptose, and yeast
extract were obtained from Difco Laboratories (Detroit, MI,
USA). Minimal essential medium (SMEM), heat-inactivated
fetal calf serum (FCS), and amino acids were from GIBCO
BRL(Gaithersburg,MD,USA);vitamins,bases,haemin,pol-
yamines, the ODC cofactor pyridoxal 5 -phosphate (PLP),
protease inhibitors, HEPES buﬀer, antibiotics, cyclohex-
imide and Rhodamine-conjugated phalloidin were pur-
chasedfromSigma(St.Louis,MO,USA).L-[1-14C]ornithine
(57.1Ci/mol) was from NEN Life Science Product, Inc
(Boston, MA). The inhibitor α-diﬂuoromethylornithine
(DFMO) was a gift from Merrell Dow Research Institute
(Cincinnati, OH).
2.2. T. cruzi Epimastigote Cultures. Epimastigote culture of Y
strain previously transfected with the green ﬂuorescent pro-
tein (GFP) gene (kindly provided by Dr S. Schenkman,
DepartamentodeMicrobiologia,ImunologiaeParasitologia,
Universidade Federal de S˜ ao Paulo (S˜ ao Paulo, SP, Brazil))
(Y-GFP) was maintained at 28◦C in rich media BHT, while
the derived culture, Y-GFP retransfected with ornithine de-
carboxylase (ODC) gene, Y-GFP-ODC population (Y-GFP-
ODC strain), and the selected clone (Y-GFP-ODC clone)
were cultured at 28◦C in a semisynthetic medium (SDM79)
which contains only traces of polyamines [38]. HaeminEnzyme Research 3
(20mg/L), 10% heat-inactivated fetal calf serum and the
antibiotics streptomycin (100μg/mL), penicillin (100U/mL)
and the selective drug G418 (250μg/mL) were added to all
cultures.
To determine the growth kinetics of each strain, a part
of Y-GFP culture was maintained in BHT while others were
placed in SDM79 medium in absence or presence of 1mM
putrescineor in Diamondin absenceor presenceof2mg/mL
glucose. Y-GFP-ODC strain and the derived clone were
maintained in SDM79 medium without or with the addi-
tion of 5mM α-diﬂuoromethylornithine (DFMO). Parasite
growth was followed by cell counting. Cultures were diluted
to 10–20 × 106 cells/mL every 48–72h, when the stationary
phase was reached.
2.3.Parasite Transfection. EpimastigoteformsofYstrain had
been previously transfected with pROCKGFPNeo and char-
acterized [7, 48]. This recombinant plasmid contains the
GFP coding region and sequences that allow a stable DNA
integration at the β-tubulin loci [7]. A selected clone from
this Y-GFP strain was retransfected with the recombinant
vector pODC7, as previously described [38]. pODC7 con-
tains the complete open reading frame (ORF) of ODC gene
from C. fasciculata [49] cloned into the expression vector
pRIBOTEX [50] that integrates at the ribosomal genes loci
[38, 51].
After transfection, parasite culture was diluted with rich
medium and incubated for 72h at 28◦C to allow its recovery
before adding the restrictive cultureconditions, consisting in
500μg/mL Geneticin (G 418) (selection by antibiotic resis-
tance) and semisynthetic medium SDM79 (selection by
polyamine autotrophy development). Subsequent growth
was followed by cell counting. Samples of T. cruzi cultures
before and after transfection were taken to analyze cellular
morphology, ﬂuorescence, and ODC activity. Drug selection
was completed 50 days after electroporation as indicated by
the mock-transfected parasites (transfected with empty p-
RIBOTEX) and the appearance of ODC activity. This time
was slightly longer than that seen in each of the previous
single-transfection cases (the T. cruzi transfection with GFP
[7]a n dw i t hO D C[ 38], in both cases selected by resistance
to 250μg/mL G418).
2.4. Selection of T. cruzi Y-GFP-ODC Clones. After selection
of the double-recombinant Y-GFP-ODC T. cruzi strain,
cloned subpopulations were obtained by diluting part of
the culture to a ﬁnal density of 0.1cells/0.2mL of SDM79
medium supplemented with 10% FCS and 250μg/mL of
G418 and plated in 96-well plates. They were incubated at
28◦C in humid chamber for 4-5 weeks and analyzed with a
ﬂuorescence or confocal microscope. GFP-expressing clones
were selected and transferred into 1mL of the same medium
in culture bottles and incubated at 28◦C. Once they reached
the plateau the cultures were expanded to 5mL and ODC
activity was assayed (see Section 3).
2.5. Preparation of Cell Extracts and ODC Enzymatic Assays.
Cell extracts were obtained and the enzymatic activity was
measured by the release of 14CO2 from L-[1-14C]ornithine
as previously described [52]. Brieﬂy, parasites were collected
at the exponential phase of growth. They were washed and
lysated by two cycles of freeze-thawing and sonication, in
buﬀer A (50mM Hepes, pH 7.4, 1mM DTT, 0.5mM EDTA
and 0.1mM pyridoxal 5 -phosphate) supplemented with
protease inhibitors and 0.5% Nonidet P40. Cell lysates were
centrifuged for 10min at 10000×g. Supernatant fractions
were tested for ODC activity by incubation at 37◦Ci n
presence of 2mM L-[1-14C] ornithine (5uCi/mL). The
enzymatic reaction was performed for the indicated times
and stopped by the addition of 0.5N perchloric acid. The
radioactive CO2 released during the reaction was trapped
on a piece of Whatman 3MM paper soaked with 2M KOH
a n dt h e nm e a s u r e di nas c i n t i l l a tion counter. Protein con-
centration was measured, using BSA as standard, according
to Bradford [53].
2.6. Kinetic Parameters of Heterologous ODC. Ornithine de-
carboxylation was carried out at diﬀerent times, substrate
and inhibitor concentrations. The determination of the ki-
neticconstantsapparentKmandVmax valuesforornithineof
the enzyme expressed in Y-GFP-ODC were calculated from
Lineweaver-Burk plots. Studies of inactivation by DFMO
were carried out as previously described [38, 54].
2.7. Trypanosoma cruzi Metacyclogenesis. For in vitro diﬀer-
entiation of T. cruzi epimastigotes, we have used a method
previously described [55, 56] with some modiﬁcations.
Brieﬂy, 25 × 106 epimastigotes from 15-day-old cultures
from Y-GFP and Y-GFP-ODC strain and clone grown in
Diamond or SDM79 media, respectively, were harvested by
centrifugation at 600×gf o r1 5m i na t1 5 ◦C. The parasites
were then incubated for 2h at 37◦Ci n5 0μLo ft r i a t o m i n e
artiﬁcial urine (TAU) medium (190mM NaCl, 17mM KCl,
2mM MgCl 2, 2mM CaCl2, 8mM phosphate buﬀer, pH
6.0). After that, parasites were diluted (1:100 dilution) in
TAU3AAG medium (TAU supplemented with 10mM L-
proline, 50mM L-sodium glutamate, 2mM L-sodium aspar-
tate, and 10mM D-glucose) and maintained for 24 or 48h
in culture ﬂasks at 28◦C[ 55, 56]. Epimastigotes treated with
α-diﬂuoromethylornithine (DFMO) or Putrescine (Put)
during metacyclogenesis were obtained by addition of 5mM
DFMO or 0,2 mM Put in both TAU and TAUAAG media at
the same conditions as controls.
Mixed parasitic forms corresponding to epimastigotes
and metacyclic trypomastigotes (E-MT suspensions) were
harvested by centrifugation at 600×gf o r1 5m i na n du s e dt o
infect Vero cells monolayers using 24-well plates containing
glass coverslips in D-MEM supplemented with 3% FBS and
antibiotics (infection medium). 24h after infection, cells
were washed, ﬁxed, and stained with Rhodamine-phalloidin
for the ﬂuorescence microscopy analysis (see below). The
metacyclogenesis capacity of these suspensions was esti-
mated by counting the percentage of infected cells. Parasites
were directly localized as green structures inside cells, where-
as host cell extension was visualized in red, as indicate in the
following.4 Enzyme Research
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Figure 1: Growth kinetics of Y-GFP and Y-GFP-ODC clone cultured at diﬀerent conditions. Cultures carried out under the indicated
conditions were diluted to 10–20 × 106 cells/mL when the stationary phase was reached. (a) Y-GFP cultured in rich media BHT
(--
￿--), Diamond(—
￿—), and in Diamond supplemented with 2mg/mL glucose (-- --). (b) Y-GFP cultured in the semisynthetic
medium SDM79 without (—
￿—)o rw i t h( --
￿--) 1mM putrescine. (c) Y-GFP-ODC clone cultured in SDM79 (—
￿—) or in SDM79
supplementedwith5mMα-diﬂuoromethylornithine(DFMO)(--
￿--).Allcultureswerecontinuouslymaintainedinpresenceof250μg/mL
G418.
2.8. Fluorescence Microscopy. For Rhodamine-phalloidin
staining, Vero cells were washed three times with PBS to
remove free extracellular parasites, ﬁxed with 3% parafor-
maldehyde solution in PBS for 10min at RT, washed with
PBS, and blocked with 50mM NH4Cl in PBS. Subsequently,
cells were permeabilized with 0.05% saponin in PBS con-
taining 0.5% BSA and then incubated with Rhodamine-
conjugated phalloidin for 1h at 37◦C to label F-actin. Cells
werewashedthreetimeswithPBSandmountedwithMowiol
before ﬂuorescence microscopy analysis. Confocal images
were obtained with an Olympus FV1000 confocal micro-
scope and the FV 10-ASW 1.7 program (Olympus, Japan).
Images were processed using Adobe7.0software (AdobeSys-
tems).
3.Results
3.1. Growth Kinetics of Y-GFP and Y-GFP-ODC Strain and
Clone. Y-GFP strain cultured in the rich medium BHT, sup-
plemented with G418, maintained the proliferative capacity
for long periods of time having a doubling time of 2-3
days and a constant maximal cell density of ∼40 × 106 para-
sites/mL (Figure 1(a)).Ontheotherhand,Y-GFPculturedin
Diamond, the rich medium habitually used for maintaining
this strain [7, 8], grew slowly with a doubling time of ap-
proximately 7 days.The maximal cell density (∼37×106 par-
asites/mL) was scarcely reached at the ﬁrst-second passage
(Figure 1(a)). To discard that the low proliferation rate was
due to low availability of glucose, an important source ofEnzyme Research 5
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Figure 2: Fluorescence microscopy of Y-GFP (a) and Y-GFP-ODC strain (b) and the selected Y-GFP-ODC clone epimastigotes (c) (1000x).
energy for T. cruzi [57], we followed the Y-GFP growth in
Diamond supplemented with 2mg/mL glucose. There were
no diﬀerences in the kinetic characteristics between both
conditions. When Y-GFP strain was cultured in the semi-
synthetic medium SDM79 (containing only traces of poly-
amines), the kinetics of growth (Figure 1(b))w a ss i m i l a rt o
thatobserved inDiamond. After10–15daysofcultureunder
thesethreeconditions,Y-GFPparasitesprogressivelystopped
growth, started decreasing, and ﬁnally were lysed. However,
when Y-GFP was cultured in SDM79 supplemented with
1mM putrescine the culture could recover the proliferation
rate (Figure 1(b)).
The double-transfected Y-GFP-ODC clone grew contin-
uously in SDM79, even better than Y-GFP in BHT, with a
doubling time of 2-3 days and a maximal cell density
of ∼80 × 106 parasites/mL (Figure 1(c)). Similar results
were obtained for the Y-GFP-ODC strain (not shown). The
continuous proliferation of the double-transfected Y-GFP-
ODCstrain andcloneinabsenceofpolyaminesindicatesthat
the original auxotrophy for diamines of T. cruzi was reversed
aftertrans-fection with the heterologousODCgene,as itwas
previously described for monotransfected strains [38].
α-diﬂuoromethylornithine (DFMO), the speciﬁc and
irreversible inhibitor of ODC, altered the growth rate of Y-
GFP-ODCclone,particularly themaximal celldensity(lower
than 55 × 106 parasites/mL) (Figure 1(c)). The partial eﬀect
of DFMO on the proliferative rate could be explained in
diﬀerent ways [58, 59] that will be discussed later.
The three cultureswere analyzed by confocalmicroscopy.
There were ∼80% of parasites expressing GFP in Y-GFP
strain, while the Y-GFP-ODC double-transfected strain and
the selected clone presented values of ∼95%, similar to those
described by Pires et al. [7].The cell morphology ofthe three
cultures was similar (Figure 2).
3.2. ODC Enzymatic Activity in Double-Transfected T. cruzi
Epimastigotes. The ODC activity was measured at 72h and
10, 20, 30, 40, and 50 days after transfection of Y-GFP T.
cruzi epimastigotes with the heterologous ODC. We have
found that double-transfected Y-GFP-ODC cells expressed
high levels of ODC activity after 50 days following trans-
fection (Figure 3(a)). It was diﬀerent from previous reports,
where a transient expression (between 48h and 7 days)
was detectable in ODC single-transfected parasites; that
expression decreased markedly during the following weeks
and recovered at 30–40 days after transfection [38]. This
diﬀerencecouldberelatedtothecellmachinery readaptation
to transcribe-translate a new foreign and active gene, doing
this already with GFP and the neomycin phosphotransferase
(neomycin resistance).
The ODC speciﬁc activity in the double-transfected Y-
GFP-ODC was around 39 ± 4nmol/h/mg prot. Once the
Y-GFP-ODC clone was selected, it showed an ODC activity
with little variation during the course of the experiment
reaching values of 590nmol/h/mg prot (Figure 3(b)). The
ODCactivity in the Y-GFP strain was, as expected, negligible
in all assays.
3.3. Properties of the Heterologous ODC Expressed in the
Selected Y-GFP-ODC Clone. The kinetic parameters of ODC
expressed in the Y-GFP-ODC clone were calculated from
a Lineweaver-Burk plot (Figure 4(a)). The estimated Vmax
value was 476.2nmoles/h/mg of protein, and the apparent
K mf o ro r n i t h i n ew a s0 . 5 1± 0.16mM. While the Km value
wassimilartothoseobtainedpreviouslyforothertransfected
T. cruzi strains [38]a n df o rC. fasciculata [60], the Vmax
was higher than those obtained in previous assays of single-
transfection with ODC gene in DFMO-sensitive strains.
Instead, the Vmax value obtained in Y-GFP-ODC clone was
similar to that observed for ODC-transfected strains after
reaching DFMO resistance [38, 58, 59].
The assays of in vivo ODCturnover(determined by stop-
ping protein synthesis with 50μg/mL cycloheximide and
measuring the remaining enzymatic activity at diﬀerent6 Enzyme Research
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Figure 3: Ornithine decarboxylase (ODC) speciﬁc activity in Y-
GFP and Y-GFP-ODC cell extracts. (a) ODC speciﬁc activity
was measured in cell extracts obtained at diﬀerent times after
transfection; (—
￿—) Y-GFP strain; (--
￿--) Y-GFP-ODC strain.
(b) ODC activity in extracts of exponentially growing cultures at 60
daysaftertransfection andcloneselection. Allvalues aretheaverage
of at least three experiments.
times) showed that the ODC expressed in Y-GFP-ODC clone
was very stable, with a half-life longer than 6h (data not
shown), remarkably longer than the half-life of the ODC
expressed in Crithidia fasciculata, its natural cellular context
[60]. This notorious change in stability has already been
observed in experiments of single transfection in other
strains of T. cruzi [38].
When Y-GFP-ODC clone was cultured in presence of
DFMO, the inhibitor was eﬀectively internalized into the cell
causing a notable ODC activity inhibition (Figure 4(b)).
Additional in vitro assays showed that DFMO inhibits the
ODC reaction in a dose-response way, with an IC50 lower
than 0.13mM (Figure 4(c)).
Based on these observations, the best explanation of why
DFMOcausedonlyamoderatedeﬀectonY-GFP-ODCclone
proliferation (Figure 1(c)) seems to be the high Vmax of
ODC activity that correlates with a high number of active
ODC molecules, making Y-GFP-ODC clone resistant to
DFMO.
3.4. T. cruzi Metacyclogenesis in Y-GFP and Y-GFP-ODC Par-
asites. We next compared the capacity of Y-GFP-ODC
(strain, and clone) and the auxotrophic Y-GFP to diﬀeren-
tiate from epimastigotes (E) to metacyclic trypomastigotes
(MT) forms using an in vitro protocol previously described
[55, 56]. Y-GFP, Y-GFP-ODC strain and Y-GFP-ODC clone
were incubated with TAU medium for 2h and subsequently
with TAU3AAG medium for 48hrs to induce T. cruzi
diﬀerentiation (TAU treatment). The MT generated for each
cell culture was estimated using the E-MT suspensions to
infect Vero cell monolayers during 24h and comparing with
theircontrols, in Diamond orSDM79media for Y-GFP orY-
GFP-ODC, respectively.
After the infection time, the cells were washed, ﬁxed and
incubated with Rhodamine-phalloidin to localize actin cy-
toskeleton of host cell by ﬂuorescence microscopy, process
that allows the clear observation of cellular limits, whereas T.
cruzi parasites were observed directly by the presence of GFP
protein. Figure 5(a) shows, at two diﬀerential ampliﬁcation
levels,confocalimagesofVerocellsinfectedbyMTgenerated
by epimastigotes of Y-GFP or Y-GFP-ODC strain under
TAU treatment. Quantiﬁcation studies indicated that the
percentage of infected cells increased when comparing
parasites obtained from Y-GFP-ODC metacyclogenesis with
the Y-GFP control (Figure 5(b),b l a c kb a r s ) ;e v e nm o r e ,i n
some cases it was possible to observe more than one Y-
GFP-ODC parasite per cell. Although the magnitude of this
increment was notas high as tobestatistically signiﬁcant, the
tendency was constant. Supporting this result, we observed
that the presence of DFMO in the metacyclogenesis assay
(seedetailsinMaterialsand Methods)impaired theinfection
of Y-GFP-ODC strain and clone, while it has no evident
eﬀect over Y-GFP (Figure 5(b), dashed bars) because the
i n h i b i t o rt a r g e ti sn o tp r e s e n ti nt h i ss t r a i n .C o n v e r s e l y ,
the percentage of infected cells was increased when Put
was added to Y-GFP parasites during the diﬀerentiation
process (Figure 5(b), grey bars) showing similar values to
those found in Y-GFP-ODC parasites. Those results indi-
cate that polyamines supply favours the E to MT conver-
sion.
Thereisanimportant numberofmorphologicalandbio-
chemical events that occur during metacyclogenesis process.
Although the molecular causes of those changes are largely
unknown, these experiments clearly show the participation
of polyamines in that process. Recently published results
showed that spermidine can regulate the transcription of
cell cycle and autophagy genes in numerous organisms
[13]. Our results show that the availability of polyamines
during T. cruzi diﬀerentiation favours the global process,
increasing the infective capacity of E-MT suspensions. As
our results were obtained by indirect infection of Vero
cells, the major infective capacity, reached in the pres-
ence of endogenous or exogenous source of polyamines,
could be explained in diﬀerent ways. Polyamines could, for
example, activate the expression of genes that participate
in diﬀerentiation from E to MT or those that code to
membrane molecules necessary for host cell interaction and
invasion, improving the quantity or quality of the process,
respectively.Enzyme Research 7
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Figure 4: ODC activity characterization. (a) Plot of Lineweaver-Burk. ODC activity was assayed in vitro at diﬀerent concentrations of
the substrate ornithine to estimate apparent Km and Vmax. (b) The Y-GFP-ODC clone was cultured in absence or presence of 5mM α-
diﬂuoromethylornithine(DFMO) for24hs,then cells were harvested, washedandODC activity wasmeasured. (c)ODC activity wascarried
out in the presence of DFMO at diﬀerent concentrations. Values in B and C are given as percentages of maximal activity. All other details as
indicated in Materials and Methods. These values are the average of two independent experiments.
4.ConcludingRemarks
Polyamines availability shows to be an important require-
ment for T. cruzi proliferation, invasion of mammalian host
cells, intracellular multiplication, and infection progression,
but the way that they act is still uncertain [1, 44, 61–63].
Unlike other trypanosomatid parasites,T .c r u z idoes not
synthesize polyamines by an endogenous ODC and relies on
the polyamine availability from the parasite external milieu
[38, 41]. However, some evidence suggests that polyamines
are not as free and available as it could be predicted by
polyamine abundance in the host; polyamines could be con-
jugatedorstoredinreservoirssotheyarenothomogeneously
distributed and equally available around all host cells and
ﬂuids or under diﬀerent treatments [37, 46]. The polyamine
content in the host relies on diet and, specially, in its ODC
enzyme, whose activity is highly regulated at multiple levels
[64]. Diﬀerent treatments that alter the host ODC activity
modulate, in turn, polyamine intracellular content—ergo
its availability for T. cruzi intracellular stages—as much as
polyamine concentration in extracellular ﬂuids, the natural
medium for bloodstream stages. In this context, the host
ODCaswell asthe parasite uptakesystemwould bepotential
targets, as by self or as a complementary target increasing
the eﬀect of antitrypanosomal therapies. As there has been
some discrepancies about the possible presence of argi-
nine decarboxylase (ADC) activity under speciﬁc metabolic
conditions [41, 42, 65–68] as well as there are clear evidence
about the presence of ADC in at least some kind of cells that
could be infected by T. cruzi [27–29], this other possible way
to obtain polyamines should be taken into account when the
roleofpolyamines amongtheT. cruzi biologicalcycleisstud-
ied. In any case, the growth curves and the results obtained
in metacyclogenesis assays support the idea that polyamines
are engaged in parasite proliferation and in diﬀerentiation
process. Therefore, this double transfected T. cruzi becomes8 Enzyme Research
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Figure 5: Metacyclogenesis of Y-GFP and Y-GFP-ODC strain and clone. After metacyclogenesis protocol (see details in Materials and
Methods),the totalmixed suspensionsof E and MT from each condition (Control,TAU, or TAU + DFMO) were used to infect Vero cells for
24h followed by detection of the host cell actin cytoskeleton as indicated under Materials and Methods. (a) Confocal images showing Vero
cells infected for 24h with T. cruzi Y-GFP and Y-GFP-ODC clone obtained from TAU medium. (b) Percentage of infected Vero cells with T.
cruzi Y-GFP, T. cruzi Y-GFP-ODC strain, and T. cruzi Y-GFP-ODC clone at indicated conditions. Data represent the mean ± SEM of at least
two independent experiments (number of counted cells ≈100). Signiﬁcantlydiﬀerent from control: ∗∗P<. 01, Bars: 10μm.
a powerful and easy-to-follow tool to study the role of
polyamines in Chagas disease pathology. In particular, the
expression of GFP gene in this double-mutant (or in new
mutantsfor othergenes),which allows a simple visualization
of T. cruzi cellular limits, represents an advantage compared
to the detection techniques frequently used (such as T. cruzi
nuclear and kinetoplast DNA Hoechst staining or indirect
immunoﬂuorescence) to localize and characterize the host
cell parasitophorous vacuole (TcPV) as well as the transit
and escape of T. cruzi from the TcPV. Further experi-
mentsofinfection in cell monolayers and animal modelswill
be done to conﬁrm and extend the knowledge about the role
ofpolyaminesinhostcellinvasion andinfectionprogression.
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